Breakout Stocks of Week 25 @ NASDAQ
NASDAQ was up last week (week 24) by 3.24% ending at 17,688.88 points after gaining 555.76 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Amedisys Inc NASDAQ:AMED. This stock has had a buy signal since Jun 03, 2024 when the price was $91.97 , but have so far fallen -0.163% to $91.82. Some other companies are on our watchlist to, among these are Columbia Banking System NASDAQ:COLB BOK Financial Corporation NASDAQ:BOKF Westamerica Bancorporation NASDAQ:WABC and AngioDynamics NASDAQ:ANGO which all got a breakout pattern emerging.
| Date | Company | Price | Week 25 |
|---|---|---|---|
| Amedisys Inc | $91.82 | $91.77 | -0.0545% |
| Columbia Banking System | $18.40 | $18.43 | 0.163% |
| Bok Financial Corporation | $87.28 | $88.20 | 1.05% |
| Westamerica Bancorporation | $45.96 | $46.73 | 1.68% |
| Angiodynamics | $6.15 | $5.88 | -4.39% |
The Amedisys Inc stock price gained 0.153% on the last trading day (Friday, 14th Jun 2024), rising from $91.68 to $91.82. During the last trading day the stock fluctuated 0.96% from a day low at $91.00 to a day high of $91.87. The price has risen in 6 of the last 10 days and is up by 0.74% over the past 2 weeks. Volume fell on the last day by -59 thousand shares and in total, 250 thousand shares were bought and sold for approximately $22.99 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
On Jul 01, 2024, it was reported that William Blair gave AMED a "Market Perform" grade with a "downgrade" action.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Amedisys Inc stock to perform well in the short-term period.
About Amedisys Inc:
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
The Columbia Banking System stock price fell by -1.29% on the last day (Friday, 14th Jun 2024) from $18.64 to $18.40. During the last trading day the stock fluctuated 1.39% from a day low at $18.35 to a day high of $18.60. The price has fallen in 6 of the last 10 days and is down by -4.56% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -424 thousand shares and in total, 1 million shares were bought and sold for approximately $19.33 million.
On Jun 27, 2024, it was reported that Wedbush gave COLB a "Underperform" grade with a "hold" action.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Columbia Banking System stock to perform well in the short-term.
About Columbia Banking System:
Columbia Banking System, Inc. operates as the bank holding company for Columbia State Bank that provides a range of banking services to small and medium-sized businesses, professionals, and individuals in the United States. It offers personal banking products and services, including noninterest and interest-bearing checking, savings, money market, and certificate of deposit accounts; home mortgages for purchases and refinances, home equity loans and lines of credit, and other personal loans; debit and credit cards; and digital banking services. The company also provides business banking products and services, such as checking, savings, interest-bearing money market, and certificate of deposit accounts; agricultural, asset-based, builder, and other commercial real estate loans, as well as loans guaranteed by the small business administration; and professional banking, treasury management, merchant card, and international banking services. In addition, it offers wealth management solutions that include financial planning services, such as asset allocation, net worth analysis, estate planning and preservation, education funding, and wealth transfer; long-term care, and life and disability insurance solutions; individual retirement solutions comprising retirement planning, retirement income strategies, and traditional and Roth individual retirement accounts; and business solutions, which comprise business retirement plans, key person insurance, business succession planning, and deferred compensation plans to individuals, families, and professional businesses. Further, the company provides fiduciary, investment, and administrative trust services, such as personal and special needs trusts, estate settlement, and investment agency and charitable management. It operates a network of 153 branch locations, including 68 in the state of Washington, 59 in Oregon, 15 in Idaho, and 11 in California. The company was founded in 1993 and is headquartered in Tacoma, Washington.
The BOK Financial Corporation stock price fell by -0.91% on the last day (Friday, 14th Jun 2024) from $88.08 to $87.28. During the last trading day the stock fluctuated 1.57% from a day low at $86.69 to a day high of $88.05. The price has fallen in 7 of the last 10 days and is down by -3.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 147 thousand shares were bought and sold for approximately $12.86 million.
On Jun 10, 2024, it was reported that Wells Fargo gave BOKF a "Sector Perform" grade with a "hold" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About BOK Financial Corporation:
BOK Financial Corporation operates as the financial holding company for BOKF, NA that provides various financial products and services in Oklahoma, Texas, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri. It operates through three segments: Commercial Banking, Consumer Banking, and Wealth Management. The Commercial Banking segment offers lending, treasury, cash management, and customer commodity risk management products for small businesses, middle market, and larger commercial customers, as well as operates TransFund electronic funds transfer network. The Consumer Banking segment provides lending and deposit services to small business customers through consumer branch network; and engages in the mortgage loan origination and servicing activities. The Wealth Management segment offers fiduciary, private bank, insurance, and investment advisory services; and brokerage and trading services primarily related to providing liquidity to the mortgage markets through trading of U.S. government agency mortgage-backed securities and related derivative contracts, as well as underwrites state and municipal securities. The company also provides commercial loans, such as loans for working capital, facilities acquisition or expansion, purchases of equipment, and other needs of commercial customers; and service, healthcare, manufacturing, wholesale/retail, energy, and other sector loans. In addition, it offers commercial real estate loans for the construction of buildings or other enhancements to real estate and property held by borrowers for investment purposes; and residential mortgage and personal loans. Further, the company provides automated teller machine (ATM), call center, and Internet and mobile banking services. As of December 31, 2021, it operated 2,593 TransFund ATM locations. The company was founded in 1910 and is headquartered in Tulsa, Oklahoma.
The Westamerica Bancorporation stock price fell by -1.35% on the last day (Friday, 14th Jun 2024) from $46.59 to $45.96. During the last trading day the stock fluctuated 1.39% from a day low at $45.73 to a day high of $46.37. The price has fallen in 7 of the last 10 days and is down by -5.86% for this period. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 69 thousand shares were bought and sold for approximately $3.16 million.
On Apr 22, 2024, it was reported that Keefe, Bruyette & Woods gave WABC a "Market Perform" grade with a "hold" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Westamerica Bancorporation:
Westamerica Bancorporation operates as a bank holding company for the Westamerica Bank that provides various banking products and services to individual and commercial customers. The company accepts various deposit products, including retail savings and checking accounts, as well as certificates of deposit. Its loan portfolio includes commercial, commercial and residential real estate, real estate construction, and consumer installment loans, as well as indirect automobile loans. It operates through 78 branch offices in 21 counties in Northern and Central California. The company was formerly known as Independent Bankshares Corporation and changed its name to Westamerica Bancorporation in 1983. The company was incorporated in 1972 and is headquartered in San Rafael, California.
The AngioDynamics stock price fell by -1.13% on the last day (Friday, 14th Jun 2024) from $6.22 to $6.15. During the last trading day the stock fluctuated 2.98% from a day low at $6.05 to a day high of $6.23. The price has risen in 5 of the last 10 days but is still down by -2.54% for this period. Volume has increased on the last day by 81 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 356 thousand shares were bought and sold for approximately $2.19 million.
On Apr 05, 2024, it was reported that Oppenheimer gave ANGO a "Outperform" grade with a "upgrade" action.
AngioDynamics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About AngioDynamics:
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
